1256.10 7.00 (0.56%)

305.19% Gain from 52W Low

37,202 Volume

NSEJan 21, 2021 03:31 PM



Astec Lifesciences Ltd.    
18 Jan 2021
1256.10
0.56%
ASTEC LIFESCIENCES LIMITED - 533138 - Board Meeting Intimation for The Meeting Of The Board Of ...
BSE India
ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months' period ended 31st December, 2020 (subject to limited review by the Statutory Auditors of the Company), after these results are reviewed by the Audit Committee. In terms of Regulation 47 of the Listing Regulations, please find enclosed herewith, copies of the Notices of the Board Meeting published in newspapers, viz., Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language) today, i.e., on 18th January, 2021.
Astec Lifesciences Ltd.    
15 Jan 2021
1256.10
0.56%
ASTEC LIFESCIENCES LIMITED - 533138 - Shareholding for the Period Ended December 31, 2020
BSE India
Astec Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
Astec Lifesciences Ltd.    
12 Jan 2021
1256.10
0.56%
Astec Lifesciences Ltd.    
11 Jan 2021
1256.10
0.56%
ASTEC LIFESCIENCES LIMITED - 533138 - Statement Of Investor Complaints For The Quarter Ended December 2020
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Tejashree PradhanDesignation :- Company Secretary and Compliance Officer
Astec Lifesciences Ltd.    
31 Dec 2020
1256.10
0.56%
ASTEC LIFESCIENCES LIMITED - 533138 - Closure of Trading Window
BSE India
This is to inform you that as per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed with effect from Friday, 1st January, 2021 till 48 (forty-eight) hours after the declaration of the Unaudited Financial Results of the Company for the Quarter and Nine Months ending 31st December, 2020. Accordingly all Officers and Designated Persons (including Directors and Auditors) of the Company have been intimated not to trade in (buy or sell) Equity Shares of the Company during the stated period.
default
Astec Lifesciences Ltd.    
18 Dec 2020
1256.10
0.56%
ASTEC LIFESCIENCES LIMITED - 533138 - Appointment Of Mr. Nandkumar Vasant Dhekne (DIN: 02189370) And Ms. ...
BSE India
This is to inform you that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors has, at its Meeting held today, i.e., on Friday, 18th December, 2020, appointed Mr. Nandkumar Vasant Dhekne [Director Identification Number (DIN): 02189370] and Ms. Anjali Rajesh Gupte [Director Identification Number (DIN): 00104884] as 'Additional Directors - Non-Executive & Independent' for a period of 5 (five) years with effect from 18th December, 2020 upto 17th December, 2025, subject to approval of the Shareholders of the Company.
Astec Lifesciences Ltd.    
18 Dec 2020
1256.10
0.56%
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Change in Directorate
BSE India
This is to inform you that based on the recommendations of the Nomination and Remuneration Committee of the Board of Directors of the Company, the Board of Directors has, at its Meeting held today, i.e., on Friday, 18th December, 2020, appointed Mr. Nandkumar Vasant Dhekne [Director Identification Number (DIN): 02189370] and Ms. Anjali Rajesh Gupte [Director Identification Number (DIN): 00104884] as 'Additional Directors - Non-Executive & Independent' for a period of 5 (five) years with effect from 18th December, 2020 upto 17th December, 2025, subject to approval of the Shareholders of the Company.
Astec Lifesciences Ltd.    
17 Dec 2020
1256.10
0.56%
Astec Lifesciences Ltd.    
27 Nov 2020
1256.10
0.56%
Astec Lifesciences Ltd.    
16 Nov 2020
1256.10
0.56%